Filed: 4/21/2026ACC: 0001193125-26-166701
📋 What this filing means
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD filed this quarterly 13F‑HR report disclosing 4 equity positions with a total reported market value of $981.81M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
4
Positions
$981.81M
Total AUM (reported)
33.14M
Total Shares
Allocation by class
SPONSORED ADS$792.94M80.8%
COM$103.27M10.5%
ORDINARY SHARES$85.60M8.7%
Portfolio Concentration
Top 3$961.47M97.9%
4–10$20.34M2.1%
Top 3 weight
97.9%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 33.14M
Sole
Full voting authority
33.14M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole4
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings4
Rows:
CENTESSA PHARMACEUTICALS PLC
SOLEShares19.96M
TypeSH
Market value$792.94M
80.76%
Sole
19.96M
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA COMPANY
SOLEShares2.67M
TypeSH
Market value$85.60M
8.72%
Sole
2.67M
Shared
0.00
None
0.00
PHATHOM PHARMACEUTICALS INC
SOLEShares7.46M
TypeSH
Market value$82.93M
8.45%
Sole
7.46M
Shared
0.00
None
0.00
AURA BIOSCIENCES INC
SOLEShares3.04M
TypeSH
Market value$20.34M
2.07%
Sole
3.04M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 19.96M | SH | $792.94M 80.76% | 19.96M | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA COMPANYSOLE | ORDINARY SHARES | 2.67M | SH | $85.60M 8.72% | 2.67M | 0.00 | 0.00 |
PHATHOM PHARMACEUTICALS INCSOLE | COM | 7.46M | SH | $82.93M 8.45% | 7.46M | 0.00 | 0.00 |
AURA BIOSCIENCES INCSOLE | COM | 3.04M | SH | $20.34M 2.07% | 3.04M | 0.00 | 0.00 |